688
D. Basa6aiah et al. / Tetrahedron: Asymmetry 12 (2001) 685–689
1,2-bis[{(5S)-1,3-diaza-2-phospha-2-oxo-3-phenylbi-
determined by HPLC using a chiral column [Chiralcel-
OD, 95:5 hexanes:i-PrOH, 0.5 mL/min, 254 nm, reten-
tion times: 20.90 min (S) and 23.63 min (R)]; IR (neat):
3408 cm−1; 1H NMR: l 2.63 (d, 1H, J=3.0 Hz),
3.59–3.82 (m, 2H), 4.88–4.96 (m, 1H), 7.28–7.49 (m,
5H); 13C NMR: l 50.77, 74.11, 126.11, 128.45, 128.67,
140.10.
cyclo(3.3.0)octan-2-yl}methylamino]cyclohexane as
a
crystalline solid (0.863 g, 76%); mp 260–262°C; [h]2D5=
+35.0 (c 1.40, CHCl3); IR (KBr): 2934, 1601, 1502,
1
1305, 1215 cm−1; H NMR: l 1.12–2.19 (m, 16H), 2.30
(s, 3H), 2.35 (s, 3H), 2.75–3.03 (m, 2H), 3.30–3.51 (m,
2H), 3.54–4.04 (m, 8H), 6.92–7.39 (m, 10H); 13C NMR:
l 25.52, 26.00, 30.62, 32.47, 45.43, 48.88 (d, J=16.3
Hz), 55.66, 58.07 (d, J=8.0 Hz), 117.47 (d, J=3.4 Hz),
121.27, 128.68, 141.64 (d, J=5.7 Hz); 31P NMR: l
23.37; MS (FAB) (m/z): 583 (M+H)+. Anal. calcd for
C30H44N6O2P2: C, 61.84; H, 7.61; N, 14.42. Found: C,
61.75; H, 7.64; N, 14.52%.
4.4. (S)-2-Bromo-1-phenylethanol 4b
Colourless oil; yield: 92%; [h]2D5=+42.45 (c 2.0, CHCl3)
[Lit.19 [h]D25=−39 (c 8.00, CHCl3), (R)-configuration,
93% e.e.]; 94% e.e., the enantiomeric purity was deter-
mined by HPLC using a chiral column [Chiralcel-OD,
95:5 hexanes:i-PrOH, 0.5 mL/min, 254 nm, retention
times: 20.48 min (S) and 23.91 min (R)]; IR (neat):
3387 cm−1; 1H NMR: l 2.62 (d, 1H, J=3.8 Hz),
3.50–3.71 (m, 2H), 4.87–5.03 (m, 1H), 7.32–7.51 (m,
5H); 13C NMR: l 40.08, 73.84, 126.03, 128.47, 128.70,
140.43.
4.2. 1,4-Bis[(5S)-1,3-diaza-2-phospha-2-oxo-3-phenylbi-
cyclo(3.3.0)octan-2-yl]piperazine 2
Compound 2 was prepared by reaction of (5S)-1,3-
diaza - 2 - phospha - 2 - oxo - 2 - chloro - 3 - phenylbicyclo-
(3.3.0)octane (1 g, 3.92 mM) with piperazine (0.169 g,
1.96 mM) at room temperature for 20 h following the
procedure for (1R,2R)-1,2-bis[{(5S)-1,3-diaza-2-phos-
pha-2-oxo-3-phenylbicyclo(3.3.0)octan-2-yl}methylam-
ino]cyclohexane 1, as a crystalline solid (0.91 g, 88%)
(after purification by column chromatography, silica
gel, 1% methanol in ethyl acetate); mp 260°C (dec.);
[h]2D5=−59.4 (c 1.4, CHCl3); IR (KBr): 2957, 1602,
4.5. (S)-2-Chloro-1-(4-methylphenyl)ethanol 4c
Colourless oil; yield: 96%; [h]2D5=+47.2 (c 1.10, CHCl3);
92% e.e., the enantiomeric purity was determined by
HPLC using a chiral column [Chiralcel-OD, 95:5 hex-
anes:i-PrOH, 0.5 mL/min, 254 nm, retention times:
21.49 min (S) and 23.54 min (R)]; IR (neat): 3414 cm−1;
1H NMR: l 2.36 (s, 3H), 2.62 (b, 1H), 3.58–3.80 (m,
2H), 4.87 (1H, dd, J=8.2, 3.8 Hz), 7.19 (d, 2H, J=7.8
Hz), 7.28 (d, 2H, J=7.8 Hz); 13C NMR: l 21.14, 50.74,
73.94, 126.02, 129.32, 137.11, 138.20.
1
1500, 1300, 1224 cm−1; H NMR: l 1.51–2.12 (m, 8H),
2.73–3.85 (m, 18H), 6.83–7.29 (m, 10H); 13C NMR: l
26.06, 32.07, 44.37, 44.97, 48.86 (d, J=16.6 Hz), 57.88
(d, J=8.0 Hz), 116.23 (d, J=3.7 Hz), 121.04, 128.93,
141.57 (d, J=5.4 Hz); 31P NMR: l 20.51; MS (ES)
(m/z): 527 (M+H)+. Anal. calcd for C26H36N6O2P2: C,
59.30; H, 6.89; N, 15.96. Found: C, 59.42; H, 6.91; N,
15.85%.
4.6. (S)-2-Chloro-1-(4-ethylphenyl)ethanol 4d
Colourless oil; yield: 84%; [h]2D5=+41.0 (c 1.0, CHCl3);
92% e.e., the enantiomeric purity was determined by
HPLC using a chiral column [Chiralcel-OD, 95:5 hex-
anes:i-PrOH, 0.5 mL/min, 254 nm, retention times:
19.00 min (S) and 20.88 min (R)]; IR (neat): 3408 cm−1;
1H NMR: l 1.23 (t, 3H, J=7.8 Hz), 2.58–2.70 (m, 3H),
3.59–3.80 (m, 2H), 4.84–4.93 (m, 1H), 7.20 (d, 2H,
J=8.2 Hz), 7.30 (d, 2H, J=8.2 Hz); 13C NMR: l 15.48,
28.58, 50.76, 74.00, 126.11, 128.14, 137.35, 144.58.
4.3. General procedure for the asymmetric reduction of
phenacyl chloride: synthesis of (S)-2-chloro-1-phenyl-
ethanol 4a
1,4-Bis[(5S)-1,3-diaza-2-phospha-2-oxo-3-phenylbicy-
clo(3.3.0)octan-2-yl]piperazine 2 (0.15 mM, 79 mg) was
first dried by azeotropic drying with anhydrous toluene
(2×3 mL) under nitrogen. The phosphoramide was then
diluted with toluene (5 mL) and to this stirred solution
borane–dimethyl sulphide (0.5 mM, 38 mg) was added
and the reaction mixture heated to 110°C. Once the
temperature was stable at 110°C, phenacyl chloride (0.5
mM, 77 mg) in toluene (1 mL) was added dropwise.
After completion of the addition, the mixture was
stirred for a further 90 min (monitored by TLC). The
reaction mixture was allowed to cool to room tempera-
ture and quenched with saturated NH4Cl solution. The
organic layer was separated and the aqueous layer were
extracted with ether (3×10 mL). The combined organic
layers were dried over anhydrous Na2SO4, and the
solvent was removed under reduced pressure. The
residue was purified by column chromatography (silica
gel, 5% ethyl acetate in hexanes) to obtain the desired
(S)-2-chloro-1-phenylethanol 4a in 91% yield (71 mg),
as a colourless oil. [h]D25=+43.5 (c 2.4, cyclohexane)
[Lit.19 [h]2D5=−48.1 (c 1.73, cyclohexane), (R)-configura-
tion, 100% e.e.]; 90% e.e., the enantiomeric purity was
4.7. (S)-2-Bromo-1-(4-methylphenyl)ethanol 4e
Colourless oil; yield: 83%; [h]2D5=+41.8 (c 1.0, CHCl3);
95% e.e., the enantiomeric purity was determined by
HPLC using a chiral column [Chiralcel-OD, 95:5 hex-
anes:i-PrOH, 0.5 mL/min, 254 nm, retention times:
26.05 min (S) and 28.58 min (R)]; IR (neat): 3375 cm−1;
1H NMR: l 2.35 (s, 3H), 2.54 (b, 1H), 3.49–3.68 (m,
2H), 4.90 (1H, dd, J=8.6, 3.8 Hz), 7.18 (d, 2H, J=8.0
Hz), 7.27 (d, 2H, J=8.0 Hz); 13C NMR: l 21.19, 40.14,
73.70, 125.93, 129.36, 137.46, 138.25.
4.8. (S)-2-Bromo-1-(4-chlorophenyl)ethanol 4f
Colourless oil; yield: 90%; [h]2D5=+38.6 (c 1.15,
CHCl3); 91% e.e., the enantiomeric purity was deter-
1
mined by H NMR spectral analysis of the correspond-
ing acetate in the presence of the chiral shift reagent,